Serine-Arginine Splicing Factors
"Serine-Arginine Splicing Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of regulatory factors essential for constitutive and alternative splicing in RNA metabolism.
| Descriptor ID |
D000068103
|
| MeSH Number(s) |
D12.776.157.725.829.500 D12.776.664.962.829.500
|
| Concept/Terms |
Serine-Arginine Splicing Factors- Serine-Arginine Splicing Factors
- Factors, Serine-Arginine Splicing
- Serine Arginine Splicing Factors
- Splicing Factors, Serine-Arginine
- Serine-Arginine-Rich Splicing Proteins
- Proteins, Serine-Arginine-Rich Splicing
- Serine Arginine Rich Splicing Proteins
- Splicing Proteins, Serine-Arginine-Rich
- SR-Rich Splicing Proteins
- Proteins, SR-Rich Splicing
- SR Rich Splicing Proteins
- Splicing Proteins, SR-Rich
|
Below are MeSH descriptors whose meaning is more general than "Serine-Arginine Splicing Factors".
Below are MeSH descriptors whose meaning is more specific than "Serine-Arginine Splicing Factors".
This graph shows the total number of publications written about "Serine-Arginine Splicing Factors" by people in this website by year, and whether "Serine-Arginine Splicing Factors" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Serine-Arginine Splicing Factors" by people in Profiles.
-
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene. 2011 Jan 20; 30(3):356-65.
-
Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin Cancer Res. 2004 Jul 15; 10(14):4652-60.